Bumper Offer - Urjas oil Just @ Rs. 1
Arigaba ME Tablet is a prescription medicine that is available as a Tablet. Neuropathic Pain, Epilepsy are some of its major therapeutic uses. The alternative uses of Arigaba ME Tablet have also been explained below.
The correct dosage of Arigaba ME Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Arigaba ME Tablet have been listed ahead. Usually, these side effects of Arigaba ME Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Arigaba ME Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Arigaba ME Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Arigaba ME Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Arigaba ME Tablet in conditions like Kidney Disease. The section on Arigaba ME Tablet contraindications lists all such conditions.
Drug reaction of Arigaba ME Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Arigaba ME Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Arigaba ME Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Arigaba ME Tablet is used -
Moderate
Mild
Is the use of Arigaba ME Tablet safe for pregnant women?
Arigaba may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Arigaba again without your doctor's advice.
Is the use of Arigaba ME Tablet safe during breastfeeding?
Arigaba may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Arigaba, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Arigaba.
What is the effect of Arigaba ME Tablet on the Kidneys?
Arigaba rarely harms the kidneys.
What is the effect of Arigaba ME Tablet on the Liver?
Arigaba does not damage the liver.
What is the effect of Arigaba ME Tablet on the Heart?
There are no any side effects of Arigaba for the heart.
Arigaba ME Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Arigaba ME Tablet unless your doctor advises you to do so -
Is this Arigaba ME Tablet habit forming or addictive?
You may get addicted to Arigaba ME Tablet. Therefore, before taking it, consult your doctor.
Is it safe to drive or operate heavy machinery when consuming?
After taking Arigaba ME Tablet, you should not drive or work on any heavy machine, as Arigaba ME Tablet can make you drowsy.
Is it safe?
Arigaba ME Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Arigaba ME Tablet can help with mental disorders.
Interaction between Food and Arigaba ME Tablet
Taking Arigaba ME Tablet with food does not cause any problems.
Interaction between Alcohol and Arigaba ME Tablet
Consuming Arigaba ME Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neurontin® (gabapentin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419-420
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 605-606
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neurontin® (gabapentin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419-420
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 605-606
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neurontin® (gabapentin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419-420
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 605-606
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 274-276
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 888
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qutenza™ (capsaicin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 729
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 201
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orudis (ketoprofen)
